Failure of carbazochrome sodium sulfonate (AC-17) to prevent dengue vascular permeability or shock: A randomized, controlled trial

Journal of Pediatrics

Volumn 131, Issue 4, 1997, Pages 525-528

  Tassniyom, S ^a   Vasanawathana, S ^a   Dhiensiri, T ^a   Nisalak, A ^a   Chirawatkul, A ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAZOCHROME; CARBAZOCHROME SODIUM SULFONATE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BLEEDING; BLOOD VESSEL PERMEABILITY; CAPILLARY PERMEABILITY; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENGUE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHOCK; THORAX RADIOGRAPHY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0031438471     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(97)70055-6     Document Type: Article

References (15)

1. S Iimura T Koyanagi Y Kato Effect of large dose of adona (AC-17) on albuminuria and hematuria Japan Medical News (Overseas Edition) Tokyo 89 1974 7 9
2. Adona 4th ed Japan pharmaceutical reference (JPR): products and administration in Japan 1996 Japan Medical Products International Trade Association Tokyo 1022 1026
3. M Hiruma N Sawada A pharmacological studies on DL-adrenochrome semi-carbazone J Osaka City Med Center 6 1957 53 59
4. Adona (AC-17) in surgical field Japan Medical News (Overseas Edition) Tokyo 42 1966 1965
5. Adona (AC-17) in obstetrical and gynecological field Japan Medical News (Overseas Edition) Tokyo 48 1967 1961
6. Y Funahara Sumarmo A Shirahata SR Harun R Dharma S Nishiyama Suppression of plasma leakage in dengue hemorrhagic fever ICMR Annals 5 1985 17 37
7. Y Funahara Sumarmo A Shirahata SR Harun R Setiabudy-Dharma MA Nathin Protection against marked plasma leakage in dengue hemorrhagic fever by infusion of carbazochrome sodium sulfonate (AC-17) Medika 13 1987 437 441
8. Y Funahara Sumarmo A Shirahata SR Harun R Setiabudy-Dharma MA Nathin Protection against marked plasma leakage in dengue hemorrhagic fever by infusion of carbazochrome sodium sulfonate (AC-17) Southeast Asian J Trop Med Public Health 18 1987 356 361
9. I Kautner M Robinson U Kuhnle Dengue virus infection: epidemiology, pathogenesis, clinical presentation, diagnosis and prevention J Pediatr 131 1997 516 524
10. AG Dean JA Dean AH Burton RC Dicker Epi Info, version 5: a work processing, database, and statistics program for epidemiology on microcomputers 1990 USD Stone Mountain (GA)
11. SPSS user’s guide 2nd ed 1986 McGraw-Hill New York
12. T Vitarana HD Silva N Withana C Gunasekera Elevated tumor necrosis factor in dengue fever and dengue hemorrhagic fever Ceylon Med J 36 1991 63 65
13. M Yadav KR Kamath N Iyngkaran M Sinnah Dengue hemorrhagic fever and dengue shock syndrome: Are the tumor necrosis factor-mediated disorders? FEMS Microbiol Immunol 4 1991 45 49
14. D Hober L Poli B Roblin P Gestas E Chungue G Granic Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients Am J Trop Med Hyg 48 1993 324 331
15. S Tassniyom S Vasanawathana A Chirawatkul S Rojanasuphot Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study Pediatrics 92 1993 111 115